Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
For type 2 diabetes , NICE guideline NG28 recommends considering GLP-1 agonists as an option when: Triple therapy with metformin and two other oral drugs is ineffective, not tolerated, or contraindicated The person has a BMI 35 kg/m (or 32.5 kg/m in people of South Asian or related ethnicity) and specific psychological or medical problems associated with obesity Insulin therapy would have significant occupational implications or weight loss would benefit other obesity-related comorbidities Treatment should be continued only if there is a beneficial metabolic response (HbA1c reduction of at least 11 mmol/mol [1.0%] and weight loss of at least 3% of initial body weight at 6 months)
A.PetersonC.WinslowD.OdehS.GaddeK
Achieve Sustainable Weight Loss Clinically Proven Treatments Balanced Nutrition Plan Expert Professional Guidance Retatrutide Dosing Schedule and Missed Doses Retatrutide is investigated as a once-weekly treatment using a gradual dose-escalation approach
Insulin detemir: from concept to clinical experience
Cognitive and Neurological Support Some peptides are being studied for brain function
Patient self-monitoring plays an important role in successful therapy
